| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | 4-Benzyloxyphenol |
| CAS No. | 103-16-2 |
| Appearance | White to off-white crystalline powder |
| Assay | ≥98% |
| Capacity | 200mt/year |
| MOQ | 100G |
| Application | Cosmetic additive and pharmaceutical intermediate |
| Standard | Enterprise export |
| Brand | FinerChem |
| More Information | Synonyms: 4-Benzyloxyphenol (PBP) 4-(Benzyloxy)phenol Hydroquinone monobenzyl ether Molecular Formula: C13H12O2 Molecular Weight: 200.24 CAS Registry Number: 103-16-2 EINECS: 203-083-3 Melting point: 117-122 ºC |
The topical application of monobenzone in animals increases the excretion of melanin from melanocytes. The same action is thought to be responsible for the depigmenting effect of the drug in humans. Monobenzone may cause destruction of melanocytes and permanent depigmentation. The histology of the skin after depigmentation with topical monobenzone is the same as that seen in vitiligo; the epidermis is normal except for the absence of identifiable melanocytes. Therefore, monobenzone is used as a topical medicine to permanently depigment normal skin surrounding vitiliginous lesions only in patients with disseminated (greater than 50 percent of body surface
1.Monobenzone Powder is a compound used as a topical drug for medical depigmentation.
2.The topical application of monobenzone powder in animals decreases the excretion of melanin from melanocytes. The same action is thought to be responsible for the depigmenting effect of the drug in humans.
3.Monobenzone Powder may cause destruction of melanocytes and permanent depigmentation.
4.The histology of the skin after depigmentation with topical monobenzone powder is the same as that seen in vitiligo.
5.The epidermis is normal except for the absence of identifiable melanocytes.
1. Monobenzone Powder is a compound used as a topical drug for medical depigmentation.
2. The topical application of monobenzone powder in animals decreases the excretion of melanin from melanocytes. The same action is thought to be responsible for the depigmenting effect of the drug in humans.
3. Monobenzone Powder may cause destruction of melanocytes and permanent depigmentation.
4. The histology of the skin after depigmentation with topical monobenzone powder is the same as that seen in vitiligo. area) idiopathic vitiligo. Monobenzone is also being considered for the treatment of Melanoma.
){kind=link}